BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8712199)

  • 1. Estimating the prevalence of drug use from self-reports in a cohort for which biologic data are available for a subsample.
    Poole WK; Flynn PM; Rao AV; Cooley PC
    Am J Epidemiol; 1996 Aug; 144(4):413-20. PubMed ID: 8712199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing drug use prevalence in the workplace: a comparison of self-report methods and urinalysis.
    Cook RF; Bernstein A
    Int J Addict; 1994 Jun; 29(8):1057-68. PubMed ID: 7960300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeated measures estimation of measurement bias for self-reported drug use with applications to the National Household Survey on Drug Abuse.
    Biemer PP; Witt M
    NIDA Res Monogr; 1997; 167():439-76. PubMed ID: 9243573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the prevalence of drug use in the general population? Simulating underreported and unknown use for more accurate national estimates.
    Levy NS; Palamar JJ; Mooney SJ; Cleland CM; Keyes KM
    Ann Epidemiol; 2022 Apr; 68():45-53. PubMed ID: 34990827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug use, self report and urinalysis.
    Kilpatrick B; Howlett M; Sedgwick P; Ghodse AH
    Drug Alcohol Depend; 2000 Feb; 58(1-2):111-6. PubMed ID: 10669061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The construct and predictive validity of different approaches to combining urine and self-reported drug use measures among older adolescents after substance abuse treatment.
    Lennox R; Dennis ML; Ives M; White MK
    Am J Addict; 2006; 15 Suppl 1():92-101. PubMed ID: 17182424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing drug use in the workplace: a comparison of self-report, urinalysis, and hair analysis.
    Cook RF; Bernstein AD; Andrews CM
    NIDA Res Monogr; 1997; 167():247-72. PubMed ID: 9243565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the accuracy of on-site multi-analyte drug testing devices in the determination of the prevalence of illicit drugs in drivers.
    Buchan BJ; Walsh JM; Leaverton PE
    J Forensic Sci; 1998 Mar; 43(2):395-9. PubMed ID: 9544550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cocaine use in obstetric patients underreported.
    Sackoff J; Kline J; Kinney A; Grunebaum A
    Am J Public Health; 1992 Jul; 82(7):1043. PubMed ID: 1609909
    [No Abstract]   [Full Text] [Related]  

  • 10. Validity of adolescent self-report of substance use.
    Williams RJ; Nowatzki N
    Subst Use Misuse; 2005; 40(3):299-311. PubMed ID: 15776978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validity of self-reported drug use in high risk populations: a meta-analytical review.
    Magura S; Kang SY
    Subst Use Misuse; 1996 Jul; 31(9):1131-53. PubMed ID: 8853234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cocaine use in women from a defined population: prevalence at delivery and effects on growth in infants.
    Weathers WT; Crane MM; Sauvain KJ; Blackhurst DW
    Pediatrics; 1993 Feb; 91(2):350-4. PubMed ID: 8424009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is quantitative urinalysis more sensitive?
    Li SH; Chiang N; Tai B; Marschke CK; Hawks RL
    NIDA Res Monogr; 1997; 175():265-86. PubMed ID: 9467804
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of positive urine drug screens in a prenatal clinic: correlation with patients' self-report of drug use.
    Ashling K; Gross AH; Coghlin DT; Sweeney PJ
    R I Med; 1994 Nov; 77(11):371-3. PubMed ID: 7812052
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonparametric discrete survival function estimation with uncertain endpoints using an internal validation subsample.
    Zee J; Xie SX
    Biometrics; 2015 Sep; 71(3):772-81. PubMed ID: 25916510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of illicit drugs detected in the urine of women of childbearing age in Alabama public health clinics.
    Pegues DA; Engelgau MM; Woernle CH
    Public Health Rep; 1994; 109(4):530-8. PubMed ID: 8041853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug use and validity of substance use self-reports in veterans seeking help for posttraumatic stress disorder.
    Calhoun PS; Sampson WS; Bosworth HB; Feldman ME; Kirby AC; Hertzberg MA; Wampler TP; Tate-Williams F; Moore SD; Beckham JC
    J Consult Clin Psychol; 2000 Oct; 68(5):923-7. PubMed ID: 11068979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug screening in newborns and mothers using meconium samples, paired urine samples, and interviews.
    Bibb KW; Stewart DL; Walker JR; Cook VD; Wagener RE
    J Perinatol; 1995; 15(3):199-202. PubMed ID: 7666268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative versus qualitative urinalysis for benzoylecgonine in clinical trials for the assessment of cocaine use.
    Li SH; Chiang CN; Tai BC; Marschke CK; Hawks RL
    Psychopharmacol Bull; 1995; 31(4):671-9. PubMed ID: 8851639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.